Abstract #1156
Pilot: MRI Differences Associated with Dutasteride and Finasteride Treatments in Patients with Low Risk Prostate Cancer
Olga Starobinets 1,2 , John Kornak 3 , John Kurhanewicz 1,2 , and Susan M Noworolski 1,2
1
Radiology and Biomedical Imaging, UCSF, San
Francisco, CA, United States,
2
Graduate
Group in Bioengineering, UC Berkeley, Berkeley, CA,
United States,
3
Epidemiology
and Biostatistics, UCSF, San Francisco, CA, United
States
Majority of imaging parameters obtained during a
prostate mpMRI scan demonstrate a better separation
between low-grade cancerous and benign regions for
prostate tissues exposed to anti-androgen therapy.
Pretreatment with dutasteride or finasteride may
facilitate a better detection of low-grade prostate
cancer.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Click here for more information on becoming a member.
